Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078331244> ?p ?o ?g. }
- W2078331244 endingPage "336" @default.
- W2078331244 startingPage "336" @default.
- W2078331244 abstract "The study aims to evaluate the effect of zinc sulfate on markers of glycemic control, lipid profile and inflammation in type-2 diabetes with microalbuminuria patients.Type-2 diabetes with microalbuminuria patients on oral hypoglycemic agents (OHA) and angiotensin converting enzyme (ACE) inhibitors were selected and divided into 2 groups: One group (n = 27) continued with OHA alone, second group (n = 27) was on OHA and in addition 50 mg elemental zinc as zinc sulphate supplementation for 12 weeks. Fasting, post-prandial blood glucose, glycosylated hemoglobin, lipid profiles, inflammatory marker hs-CRP and urine microalbumin were measured.There were no significant differences in biochemical status among groups at baseline. After receiving zinc, the mean fasting blood glucose (FBS), post-prandial blood glucose (PPBS) and glycosylated hemoglobin (HbA1c) were decreased significantly (P = 0.0001). Significant decrease was observed in TG (P = 0.002) and VLDL-cholesterol (P = 0.002), whereas there was no significant decrease in TC and LDL-cholesterol. The high-density lipoprotein (HDL) cholesterol was significantly (P = 0.0001) increased from baseline. Zinc supplementation had significant effects in decreasing serum hs-CRP from 10.51 ± 1.68 mg/L to 7.75 ± 1.56 mg/L (P = 0.0001) and microalbumin level from 146.87 ± 30.83 mg/day to 80.70 ± 33.99 mg/day (P = 0.0001). There were no significant changes in the levels of all these parameters in OHA group.Our results conclude that supplementation of zinc improved the effectiveness of OHA and may be beneficial in decreasing blood glucose, TG, urinary albumin excretion and inflammation in diabetic nephropathy patients and thus reducing the risk of complications." @default.
- W2078331244 created "2016-06-24" @default.
- W2078331244 creator A5012595037 @default.
- W2078331244 creator A5016126411 @default.
- W2078331244 creator A5020065419 @default.
- W2078331244 creator A5045984903 @default.
- W2078331244 creator A5065485781 @default.
- W2078331244 creator A5076427919 @default.
- W2078331244 date "2013-01-01" @default.
- W2078331244 modified "2023-09-27" @default.
- W2078331244 title "Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients" @default.
- W2078331244 cites W1481144095 @default.
- W2078331244 cites W1499817430 @default.
- W2078331244 cites W1925247835 @default.
- W2078331244 cites W1963025550 @default.
- W2078331244 cites W1967344340 @default.
- W2078331244 cites W1982001623 @default.
- W2078331244 cites W1988928503 @default.
- W2078331244 cites W1999319033 @default.
- W2078331244 cites W2005227623 @default.
- W2078331244 cites W2022608437 @default.
- W2078331244 cites W2035152237 @default.
- W2078331244 cites W2049801032 @default.
- W2078331244 cites W2064911760 @default.
- W2078331244 cites W2083911580 @default.
- W2078331244 cites W2092787054 @default.
- W2078331244 cites W2100360021 @default.
- W2078331244 cites W2111251212 @default.
- W2078331244 cites W2111690670 @default.
- W2078331244 cites W2115894981 @default.
- W2078331244 cites W2119876100 @default.
- W2078331244 cites W2146144003 @default.
- W2078331244 cites W2157236165 @default.
- W2078331244 cites W2164409045 @default.
- W2078331244 cites W2171285048 @default.
- W2078331244 cites W2396247338 @default.
- W2078331244 doi "https://doi.org/10.4103/0976-9668.117002" @default.
- W2078331244 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3783776" @default.
- W2078331244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24082728" @default.
- W2078331244 hasPublicationYear "2013" @default.
- W2078331244 type Work @default.
- W2078331244 sameAs 2078331244 @default.
- W2078331244 citedByCount "59" @default.
- W2078331244 countsByYear W20783312442014 @default.
- W2078331244 countsByYear W20783312442015 @default.
- W2078331244 countsByYear W20783312442016 @default.
- W2078331244 countsByYear W20783312442017 @default.
- W2078331244 countsByYear W20783312442018 @default.
- W2078331244 countsByYear W20783312442019 @default.
- W2078331244 countsByYear W20783312442020 @default.
- W2078331244 countsByYear W20783312442021 @default.
- W2078331244 countsByYear W20783312442022 @default.
- W2078331244 countsByYear W20783312442023 @default.
- W2078331244 crossrefType "journal-article" @default.
- W2078331244 hasAuthorship W2078331244A5012595037 @default.
- W2078331244 hasAuthorship W2078331244A5016126411 @default.
- W2078331244 hasAuthorship W2078331244A5020065419 @default.
- W2078331244 hasAuthorship W2078331244A5045984903 @default.
- W2078331244 hasAuthorship W2078331244A5065485781 @default.
- W2078331244 hasAuthorship W2078331244A5076427919 @default.
- W2078331244 hasBestOaLocation W20783312442 @default.
- W2078331244 hasConcept C126322002 @default.
- W2078331244 hasConcept C134018914 @default.
- W2078331244 hasConcept C139572402 @default.
- W2078331244 hasConcept C178790620 @default.
- W2078331244 hasConcept C185592680 @default.
- W2078331244 hasConcept C2777180221 @default.
- W2078331244 hasConcept C2777538456 @default.
- W2078331244 hasConcept C2778163477 @default.
- W2078331244 hasConcept C2778270857 @default.
- W2078331244 hasConcept C2778917026 @default.
- W2078331244 hasConcept C2779922275 @default.
- W2078331244 hasConcept C2780473172 @default.
- W2078331244 hasConcept C2781203188 @default.
- W2078331244 hasConcept C535196362 @default.
- W2078331244 hasConcept C555293320 @default.
- W2078331244 hasConcept C71924100 @default.
- W2078331244 hasConceptScore W2078331244C126322002 @default.
- W2078331244 hasConceptScore W2078331244C134018914 @default.
- W2078331244 hasConceptScore W2078331244C139572402 @default.
- W2078331244 hasConceptScore W2078331244C178790620 @default.
- W2078331244 hasConceptScore W2078331244C185592680 @default.
- W2078331244 hasConceptScore W2078331244C2777180221 @default.
- W2078331244 hasConceptScore W2078331244C2777538456 @default.
- W2078331244 hasConceptScore W2078331244C2778163477 @default.
- W2078331244 hasConceptScore W2078331244C2778270857 @default.
- W2078331244 hasConceptScore W2078331244C2778917026 @default.
- W2078331244 hasConceptScore W2078331244C2779922275 @default.
- W2078331244 hasConceptScore W2078331244C2780473172 @default.
- W2078331244 hasConceptScore W2078331244C2781203188 @default.
- W2078331244 hasConceptScore W2078331244C535196362 @default.
- W2078331244 hasConceptScore W2078331244C555293320 @default.
- W2078331244 hasConceptScore W2078331244C71924100 @default.
- W2078331244 hasIssue "2" @default.
- W2078331244 hasLocation W20783312441 @default.
- W2078331244 hasLocation W20783312442 @default.
- W2078331244 hasLocation W20783312443 @default.
- W2078331244 hasLocation W20783312444 @default.